BioengineeringbioRxivPreprint
Precision at Every Scale: Efficiency in AI-Driven De Novo Antibody Design
Hyeonjin Cha, Kyesoo Cho, Jeonghyeon Gu…·Jinsol Yang
This paper evaluates GaluxDesign, an AI platform, for de novo antibody design, showing a 10.5% binder rate and strong performance on benchmark targets.
DOI 10.1101/2025.11.21.689414